Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
GEORGE TOWN, CAYMAN ISLANDS, March 11, 2026 (GLOBE NEWSWIRE) -- Metals Acquisition Corp. II (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price...
-
VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery,...
-
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- GalaxyEdge Acquisition Corporation (NYSE: GLEDU or the “Company”), today announced that the underwriters of its recently announced initial public...
-
Today, Robinhood Ventures Fund I (RVI) announced the pricing of its initial public offering
-
REalloys Announces Proposed Public Offering of Common Stock
-
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- GalaxyEdge Acquisition Corp (NYSE: GLEDU, the “Company”) announced today that it closed its initial public offering (“IPO”) of 10,000,000 units at an...
-
SASKATOON, Saskatchewan, March 04, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 213,519 options to purchase common shares to...
-
RESEARCH TRIANGLE PARK, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the compensation committee of BioCryst’s board of directors granted...
-
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- GalaxyEdge Acquisition Corp, a blank check company incorporated in the Cayman Islands as an exempted company (the “Company”), today announced the pricing...
-
WAYNE, Pa., March 02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel...